A1M is a natural, endogenous protein which has many functions in the body, such as free radical inhibition and tissue repair. It is a candidate for many diverse therapeutic and diagnostic applications.
Preclinical studies suggest that A1M could be used as a drug to counteract the detrimental effects of pre-eclampsia—a potentially fatal condition that affects over eight million pregnant women each year. A1M has also been shown to repair tissues.
A1M Pharma’s research over the last five years has shown that the kidneys are amongst the organs which are best protected by the A1M protein. The company has therefore recently devoted resources to developing treatments for kidney damage.